$DRCT stock has now risen 20% today, according to our price data from Polygon. There has been approximately $34,966,551 of trading volume.
Here is what we see in our data on $DRCT (you can track the company live on Quiver's $DRCT stock page):$DRCT Insider Trading Activity
$DRCT insiders have traded $DRCT stock on the open market 28 times in the past 6 months. Of those trades, 0 have been purchases and 28 have been sales.
Here’s a breakdown of recent trading of $DRCT stock by insiders over the last 6 months:
- MARK D WALKER (Chairman and CEO) has made 0 purchases and 12 sales selling 196,069 shares for an estimated $94,022.
- W KEITH SMITH (President) has made 0 purchases and 11 sales selling 156,700 shares for an estimated $82,317.
- RICHARD COHEN has made 0 purchases and 2 sales selling 10,270 shares for an estimated $5,511.
- ANTOINETTE RENEE LEATHERBERRY has made 0 purchases and 2 sales selling 6,037 shares for an estimated $3,279.
- MISTELLE LOCKE sold 3,432 shares for an estimated $1,784
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DRCT Hedge Fund Activity
We have seen 6 institutional investors add shares of $DRCT stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 99,239 shares (+60511.6%) to their portfolio in Q2 2025, for an estimated $56,070
- TWO SIGMA SECURITIES, LLC added 53,165 shares (+inf%) to their portfolio in Q2 2025, for an estimated $30,038
- XTX TOPCO LTD added 38,534 shares (+252.6%) to their portfolio in Q2 2025, for an estimated $21,771
- VIRTU FINANCIAL LLC removed 30,196 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $17,060
- VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC removed 22,097 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,484
- TWO SIGMA INVESTMENTS, LP added 16,054 shares (+inf%) to their portfolio in Q2 2025, for an estimated $9,070
- BLACKROCK, INC. removed 8,335 shares (-51.6%) from their portfolio in Q2 2025, for an estimated $4,709
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DRCT Analyst Ratings
Wall Street analysts have issued reports on $DRCT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Buy" rating on 05/07/2025
To track analyst ratings and price targets for $DRCT, check out Quiver Quantitative's $DRCT forecast page.
You can track data on $DRCT on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
